Blind round 3: 40 harder SEC filing questions, Signal8 Octo ranked #1 again
BLIND ROUND 3 · answers collected 2026-11-11 · 40 questions · filing not named · keys sealed before any tool ran
Signal8's Octo ranked #1 in our second blind round, a harder test of 40 SEC filing questions that do not say which filing holds the answer: 156 of 160, zero wrong figures. Claude also scored 156 with no wrong figure and ranks second on the published tie-break; ChatGPT scored 145 and AskEdgar Studio 132. Perplexity (137 on 39 answers) and Gemini (80 on 28) did not finish on their free plans. Signal8 runs this lab and makes Octo.
Our top pick · ranked #1 in both blind rounds
Octo, Signal8's AI research assistant
- Top score again: 156 of 160, shared with Claude, ahead of ChatGPT (145) and AskEdgar Studio (132). Over both blind rounds: 316 of 320, also shared with Claude.
- Zero wrong figures in 80 questions across the two blind rounds.
- Octo cited the SEC filing itself on 77 of 80 answers and never relied on a third-party site. Claude linked the filing on 63 of 80 and linked other websites on 59.
Results and ranking
Tie-break used: Octo and Claude both scored 156 of 160 in round 3 with no wrong figure, and 316 of 320 over both blind rounds. No strict re-score was made for round 3, so the tie is broken by the two rounds' combined record: wrong figures across all 80 questions (0 each, still level), then answers that linked the original SEC filing (Octo 77 of 80, Claude 63 of 80). This is Signal8's rule, chosen after round 3 was graded; Octo did not outscore Claude.
| Rank | Tool and run conditions | Answered | Figure correct | Cites a source | Source has it | As-of right | Score | 4 of 4 | Wrong figures |
|---|---|---|---|---|---|---|---|---|---|
| #1 | Signal8 Octo Ranked first: top score, zero wrong figures, first on the tie-break. Made by Signal8. signal8.ai/octo in production, on a Signal8 staff account | 40 of 40 | 40 | 40 | 36 | 40 | 156 / 160 | 36 | 0 |
| #2 | Claude claude.ai with web search on; none of its answers used Signal8, DilutionScan or SplitScanner data | 40 of 40 | 40 | 40 | 36 | 40 | 156 / 160 | 36 | 0 |
| #3 | ChatGPT Free plan, signed in, default model, web search | 40 of 40 | 38 | 35 | 34 | 38 | 145 / 160 | 33 | 2 |
| #4 | AskEdgar Studio Studio agent on a paid account (Studio is in AskEdgar Pro, listed at $59 a month) | 40 of 40 | 35 | 31 | 27 | 39 | 132 / 160 | 27 | 5 (1 stale) |
| Not ranked | Perplexity Free plan on a Signal8 team account; one answer (R3-14) was not captured | 39 of 40 | 34 | 37 | 28 | 38 | 137 / 156 | 28 | 5 (1 stale) |
| Not ranked | Gemini Free tier; 12 questions were blocked by its free usage limit | 28 of 40 | 23 | 17 | 13 | 27 | 80 / 112 | 13 | 5 |
In order: #1 Signal8 Octo (156), #2 Claude (156), #3 ChatGPT (145), #4 AskEdgar Studio (132). Not ranked because the run was incomplete: Perplexity, 137 of 156 on 39 answers, and Gemini, 80 of 112 on 28. AskEdgar Studio finished fourth of the four complete runs with 5 wrong figures (R3-12, R3-29 stale, R3-35, R3-39, R3-40), 24 marks behind Octo.
Downloads: every grade with the grader's note (CSV), the sealed answer keys (JSON), the blind label mapping and the second-pass mapping (JSON), the grader instructions and the citation-source code for every answer.
Where the answer came from
Octo cited the SEC filing itself on 77 of 80 answers and never relied on a third-party site. The table counts, for each graded answer, whether the links on the tool's page went to the filing itself or to another website.
| Tool | Answers counted | Linked the original SEC filing | Linked another website | Other websites only | Round 2 / round 3: SEC filing linked |
|---|---|---|---|---|---|
| Signal8 Octo Made by Signal8, which runs this lab | 80 | 77 of 80 | 0 of 80 | 0 of 80 | 38 of 40 / 39 of 40 |
| Claude | 80 | 63 of 80 | 59 of 80 | 17 of 80 | 29 of 40 / 34 of 40 |
| ChatGPT | 80 | 50 of 80 | 12 of 80 | 6 of 80 | 31 of 40 / 19 of 40 |
| AskEdgar Studio | 80 | 26 of 80 | 1 of 80 | 0 of 80 | 16 of 40 / 10 of 40 |
| Perplexity | 79 | 51 of 79 | 27 of 79 | 16 of 79 | 24 of 40 / 27 of 39 |
| Gemini | Not measured | Not measured | Not measured | Not measured | Not measured |
Gemini is not measured: its links could not be captured from its page, so we report no figure rather than a zero. Perplexity counts 79 answers because one round 3 answer was not captured. Linking another website is not wrong in itself; it means part of the answer rests on a page that is not the filing. Per-answer codes: citation-sources.json.
Octo's four lost marks
Every figure Octo gave was right. It lost one mark each on R3-02, R3-07, R3-12, R3-27, all questions that count reverse splits across several filings: the filings it cited did not cover every split, because it cited the deciding 8-K for some splits only, or cited a split outside the window as context. Claude lost four "source has it" marks too (R3-12, R3-16, R3-27, R3-30). A fix so that Octo cites each split's own 8-K when counting splits is in progress at Signal8; it is not part of these results.
Read these caveats first
- The tie-break was chosen after grading. Octo and Claude are level on score and on wrong figures. First place rests on the combined record of linking the original filing, a criterion Signal8 picked on November 12 with the grades known. Round 4 fixes its rule in advance (round 4 protocol).
- Perplexity and Gemini were graded in a second pass. Their answers were graded blind after the first four tools, by fresh Claude graders under the same instructions, in packets holding only their two answers. They did not sit beside the other four tools' answers.
- Two runs are incomplete. Gemini's free tier blocked 12 questions with its usage limit, and one Perplexity answer (R3-14) was not captured. Their totals are on fewer questions and are not ranked.
- The grader is the same model family as a contestant. The graders were Claude instances and Claude is one of the tools. They saw no tool names, but we cannot rule out that they read Claude-style answers more kindly.
- A key was corrected during grading. R3-22's key says the 1-for-8 split took effect April 17, 2026; the 8-K says April 21 (April 17 was the announcement). Graders credited April 21. No score changed. The key file is published unedited so its hash still matches.
- Different plans. ChatGPT, Perplexity and Gemini ran on free plans, AskEdgar Studio on a paid account, Octo on Signal8's production service with a staff account.
- Signal8 runs this lab and makes Octo. Signal8 chose the questions, wrote the keys and ran every tool.
How round 3 worked
- Harder questions. Round 2 named the exact filing in every question, and the top four scored 158 to 160. Round 3 never names the filing. Each question is pinned to a past date or window, and each needs at least one of: a late filer whose newest 10-Q was filed after the as-of date, a newer 10-Q that changed the cash runway, several reverse-split 8-Ks counted and multiplied with one split just outside the window, an old figure split-adjusted without double counting, a superseded agreement or repriced warrant, an amended 10-Q or 10-K, a footnote table, a cover-page versus balance-sheet share count, or several Form 4s summed. 40 different small and micro caps: 7 dilution, 8 reverse splits, 8 cash and runway, 8 shares and float, 9 other.
- Sealed keys. Every key was checked by script against the primary filings on sec.gov (87 accessions in all, with trap filings marked). The key file was sealed at 2026-11-11T03:34:51Z with SHA-256
ff6521e1154f5fb11c445424eeba407efb20cebecae02da73a610b92fe05f03c, before any tool was asked. Download the same file to check the hash. - Asking. Each tool got each question verbatim in a fresh chat, with no follow-up, on November 11, 2026.
- Blind grading. For the first four tools, all answers to a question were shuffled and labelled A to D, with tool names and tool-identifying links removed, and graded by eight fresh Claude instances that saw only the instructions, the key and the anonymous answers. Perplexity's and Gemini's answers were graded the same way in a second pass, labelled A and B. Hashes of the packets (not published, because they hold raw answer text) and of the mappings:
d750622b8f22bec936e6067830f8a4b3ded2e6b2bcf8c757668daadf46df6418 grading/packets.json;8cc9abe44a1f0cef0936a9ec183a9bd3aad95210fc377702b64cfa4f64b2c814 grading/mapping.json;0ff47033fa7497c6c738b87d3ddb2e05f33aa114a350fbf8db33e15afd0b6d93 grading/pg/packets.json;5bb96dbfa469aa6bb71eb68351671738459b6ba972d25db5e8a443c15b4a1283 grading/pg/mapping.json. - Four marks per answer. Figure correct (every part; a figure from a trap filing is a fail, tagged stale), cites a source, the cited source states the figure, and as-of date right.
Every question and every grade
Marks are out of 4. A dash means no answer was recorded. Full grader notes for all 240 rows are in the CSV.
| Q | Ticker | Topic | Octo | Claude | ChatGPT | AskEdgar | Perplexity | Gemini |
|---|---|---|---|---|---|---|---|---|
| R3-01 | LIDR | ATM, warrants or shelf | 4 | 4 | 4 | 4 | 2 | 2 |
| R3-02 | XXII | Reverse splits | 3 | 4 | 4 | 2 | 3 | 2 |
| R3-03 | EONR | Cash and runway | 4 | 4 | 4 | 4 | 4 | 4 |
| R3-04 | ONFO | Shares and float | 4 | 4 | 4 | 4 | 4 | 4 |
| R3-05 | RNXT | Nasdaq status (8-K) | 4 | 4 | 4 | 2 | 4 | 2 |
| R3-06 | CODX | ATM, warrants or shelf | 4 | 4 | 4 | 4 | 4 | 1 |
| R3-07 | JAGX | Reverse splits | 3 | 4 | 4 | 2 | 4 | 2 |
| R3-08 | SEGG | Cash and runway | 4 | 4 | 4 | 4 | 4 | 2 |
| R3-09 | SURG | Shares and float | 4 | 4 | 4 | 4 | 1 | 4 |
| R3-10 | BFRG | Nasdaq status (8-K) | 4 | 4 | 3 | 2 | 4 | 2 |
| R3-11 | ECOR | ATM, warrants or shelf | 4 | 4 | 4 | 4 | 4 | 4 |
| R3-12 | IVF | Reverse splits | 3 | 3 | 2 | 1 | 2 | 2 |
| R3-13 | CELU | Cash and runway | 4 | 4 | 4 | 4 | 4 | 4 |
| R3-14 | MITI | Shares and float | 4 | 4 | 4 | 4 | - | 4 |
| R3-15 | NUAI | Amended filing | 4 | 4 | 4 | 4 | 4 | 4 |
| R3-16 | VTGN | ATM, warrants or shelf | 4 | 3 | 4 | 4 | 2 | 2 |
| R3-17 | NVVE | Reverse splits | 4 | 4 | 4 | 4 | 4 | 2 |
| R3-18 | XTIA | Cash and runway | 4 | 4 | 4 | 4 | 4 | 4 |
| R3-19 | YHC | Shares and float | 4 | 4 | 4 | 4 | 4 | 4 |
| R3-20 | RR | Amended filing | 4 | 4 | 4 | 4 | 4 | 4 |
| R3-21 | DCOY | ATM, warrants or shelf | 4 | 4 | 4 | 4 | 4 | 2 |
| R3-22 | KITT | Reverse splits | 4 | 4 | 4 | 2 | 4 | 2 |
| R3-23 | TELO | Cash and runway | 4 | 4 | 4 | 4 | 4 | 2 |
| R3-24 | HLSQ | Shares and float | 4 | 4 | 4 | 4 | 4 | 1 |
| R3-25 | ROLR | Amended filing | 4 | 4 | 4 | 4 | 4 | 4 |
| R3-26 | WWR | ATM, warrants or shelf | 4 | 4 | 4 | 4 | 4 | 4 |
| R3-27 | SLXN | Reverse splits | 3 | 3 | 2 | 2 | 2 | 2 |
| R3-28 | ALGS | Cash and runway | 4 | 4 | 4 | 4 | 4 | 4 |
| R3-29 | SGLY | Shares and float | 4 | 4 | 4 | 1 | 4 | - |
| R3-30 | CISO | Nasdaq status (8-K) | 4 | 3 | 4 | 2 | 4 | - |
| R3-31 | EZRA | ATM, warrants or shelf | 4 | 4 | 4 | 4 | 4 | - |
| R3-32 | NXXT | Reverse splits | 4 | 4 | 2 | 2 | 4 | - |
| R3-33 | ELTX | Cash and runway | 4 | 4 | 4 | 4 | 4 | - |
| R3-34 | NAII | Shares and float | 4 | 4 | 4 | 4 | 4 | - |
| R3-35 | HEPA | Insider purchases (Form 4) | 4 | 4 | 2 | 2 | 3 | - |
| R3-36 | PFSA | Reverse splits | 4 | 4 | 0 | 4 | 2 | - |
| R3-37 | NXTC | Cash and runway | 4 | 4 | 4 | 4 | 4 | - |
| R3-38 | TGL | Shares and float | 4 | 4 | 4 | 4 | 2 | - |
| R3-39 | PMTS | Insider purchases (Form 4) | 4 | 4 | 4 | 2 | 3 | - |
| R3-40 | INV | Insider purchases (Form 4) | 4 | 4 | 2 | 2 | 3 | - |
R3-01 · ATM, warrants or shelf · LIDR
As of September 30, 2026, how much capacity remained available under AEye, Inc.'s (LIDR) at-the-market equity program with A.G.P., and under which agreement?
Sealed key: $50.0 million: the full amount of the new At Market Issuance Sales Agreement dated September 15, 2026 (no sales through September 30, 2026). The prior A.G.P. ATM agreement (raised to $125 million; $70.4 million sold) was terminated on September 15, 2026. As of: September 30, 2026.
Filings in the key: 424B5 filed 2026-09-15 (0000947871-26-000869), new ATM prospectus supplement; 10-Q filed 2026-11-06 (0001437749-26-035565), Q3 10-Q; 10-Q filed 2026-08-06 (0001437749-26-026354), trap: superseded Q2 figure.
| Tool | Figure | Cites | Source has it | As-of | Links went to |
|---|---|---|---|---|---|
| Signal8 Octo | yes | yes | yes | yes | SEC filing |
| Claude | yes | yes | yes | yes | SEC filing and other sites |
| ChatGPT | yes | yes | yes | yes | no link captured |
| AskEdgar Studio | yes | yes | yes | yes | no link captured |
| Perplexity second blind pass | yes | no | no | yes | no link captured |
| Gemini second blind pass | yes | no | no | yes | Not measured |
R3-02 · Reverse splits · XXII
How many reverse stock splits did 22nd Century Group (XXII) make effective between January 1, 2024 and October 31, 2026 (inclusive), what was each ratio, and what is the combined (cumulative) reverse-split factor over that window?
Sealed key: Five reverse splits: 1-for-16 (effective April 2, 2024), 1-for-135 (December 17, 2024), 1-for-23 (June 20, 2025), 1-for-15 (January 26, 2026) and 1-for-20 (June 12, 2026). Cumulative factor 16 x 135 x 23 x 15 x 20 = 14,904,000 (i.e. 1-for-14,904,000). As of: Window January 1, 2024 to October 31, 2026.
Filings in the key: 8-K filed 2024-04-03 (0001104659-24-043130), split 1; 8-K filed 2024-12-17 (0001104659-24-129440), split 2; 8-K filed 2025-06-16 (0001641172-25-015296), split 3; 8-K filed 2026-01-22 (0001493152-26-003185), split 4; 8-K filed 2026-06-09 (0001493152-26-027838), split 5; 8-K filed 2026-11-03 (0001493152-26-049743), trap: outside window.
| Tool | Figure | Cites | Source has it | As-of | Links went to |
|---|---|---|---|---|---|
| Signal8 Octo | yes | yes | no | yes | SEC filing |
| Claude | yes | yes | yes | yes | SEC filing and other sites |
| ChatGPT | yes | yes | yes | yes | SEC filing and other sites |
| AskEdgar Studio | yes | no | no | yes | no link captured |
| Perplexity second blind pass | yes | yes | no | yes | other sites only |
| Gemini second blind pass | yes | no | no | yes | Not measured |
R3-03 · Cash and runway · EONR
Using only reports EON Resources (EONR) had filed with the SEC on or before October 1, 2026: what was the company's most recently reported balance-sheet cash and cash equivalents, and as of what date?
Sealed key: $375,036 as of December 31, 2025 (FY2025 Form 10-K filed September 28, 2026). Its Q1 and Q2 2026 10-Qs were not filed until October 13 and October 22, 2026. As of: December 31, 2025 balance; reports filed on or before October 1, 2026.
Filings in the key: 10-K filed 2026-09-28 (0001213900-26-103762), 10-K FY2025.
| Tool | Figure | Cites | Source has it | As-of | Links went to |
|---|---|---|---|---|---|
| Signal8 Octo | yes | yes | yes | yes | SEC filing |
| Claude | yes | yes | yes | yes | SEC filing and other sites |
| ChatGPT | yes | yes | yes | yes | no link captured |
| AskEdgar Studio | yes | yes | yes | yes | no link captured |
| Perplexity second blind pass | yes | yes | yes | yes | SEC filing |
| Gemini second blind pass | yes | yes | yes | yes | Not measured |
R3-04 · Shares and float · ONFO
In the most recent Form 10-Q that Onfolio Holdings (ONFO) had filed on or before October 31, 2026, how many shares of common stock were outstanding as of the cover-page date, and how many were issued and outstanding on the balance sheet at the end of the quarter?
Sealed key: Cover: 2,452,712 shares outstanding as of August 19, 2026. Balance sheet: 150,462 shares at June 30, 2026 (10-Q for the quarter ended June 30, 2026). As of: Cover date August 19, 2026; balance sheet June 30, 2026.
Filings in the key: 10-Q filed 2026-08-19 (0001654954-26-007754), Q2 2026 10-Q.
| Tool | Figure | Cites | Source has it | As-of | Links went to |
|---|---|---|---|---|---|
| Signal8 Octo | yes | yes | yes | yes | SEC filing |
| Claude | yes | yes | yes | yes | SEC filing and other sites |
| ChatGPT | yes | yes | yes | yes | SEC filing |
| AskEdgar Studio | yes | yes | yes | yes | no link captured |
| Perplexity second blind pass | yes | yes | yes | yes | SEC filing |
| Gemini second blind pass | yes | yes | yes | yes | Not measured |
R3-05 · Nasdaq status (8-K) · RNXT
As of October 31, 2026, was RenovoRx (RNXT) still out of compliance with Nasdaq's $1.00 minimum bid price requirement? If so, what was its deadline; if not, when did it regain compliance?
Sealed key: No. Nasdaq confirmed on August 20, 2026 that RNXT had regained compliance (closing bid at or above $1.00 for ten consecutive business days, August 6-19, 2026); the matter was closed. Its second compliance period had run to December 28, 2026. As of: October 31, 2026.
Filings in the key: 8-K filed 2026-08-20 (0001493152-26-039472), compliance regained; 8-K filed 2026-07-02 (0001493152-26-031662), trap: superseded deadline.
| Tool | Figure | Cites | Source has it | As-of | Links went to |
|---|---|---|---|---|---|
| Signal8 Octo | yes | yes | yes | yes | SEC filing |
| Claude | yes | yes | yes | yes | SEC filing and other sites |
| ChatGPT | yes | yes | yes | yes | SEC filing and other sites |
| AskEdgar Studio | yes | no | no | yes | no link captured |
| Perplexity second blind pass | yes | yes | yes | yes | SEC filing and other sites |
| Gemini second blind pass | no | yes | no | yes | Not measured |
R3-06 · ATM, warrants or shelf · CODX
As of September 30, 2026, how many common stock purchase warrants did Co-Diagnostics (CODX) have outstanding in total, and how many of the warrants issued in its May 2026 private placement were still outstanding?
Sealed key: 5,012,756 warrants outstanding in total (15,500 2021 acquisition warrants + 1,592,532 May 2026 warrants + 3,404,724 July 2026 inducement warrants). 1,592,532 May 2026 warrants remained (3,294,894 issued, 1,702,362 exercised in the July/August 2026 inducement). As of: September 30, 2026.
Filings in the key: 10-Q filed 2026-11-10 (0001493152-26-050963), Q3 10-Q; 8-K filed 2026-07-31 (0001493152-26-035553), inducement 8-K.
| Tool | Figure | Cites | Source has it | As-of | Links went to |
|---|---|---|---|---|---|
| Signal8 Octo | yes | yes | yes | yes | SEC filing |
| Claude | yes | yes | yes | yes | SEC filing and other sites |
| ChatGPT | yes | yes | yes | yes | SEC filing |
| AskEdgar Studio | yes | yes | yes | yes | no link captured |
| Perplexity second blind pass | yes | yes | yes | yes | SEC filing |
| Gemini second blind pass | no | no | no | yes | Not measured |
R3-07 · Reverse splits · JAGX
Between January 1, 2024 and October 31, 2026, how many reverse stock splits did Jaguar Health (JAGX) effect, at what ratios, and what is the cumulative reverse-split factor across them?
Sealed key: Four: 1-for-60 (effective May 23, 2024), 1-for-25 (March 24, 2025), 1-for-35 (April 30, 2026) and 1-for-15 (September 17, 2026). Cumulative factor 60 x 25 x 35 x 15 = 787,500 (1-for-787,500). As of: Window January 1, 2024 to October 31, 2026.
Filings in the key: 8-K filed 2024-05-23 (0001104659-24-064484), split 1; 8-K filed 2025-03-18 (0000950170-25-040784), split 2; 8-K filed 2026-04-27 (0001193125-26-179391), split 3; 8-K filed 2026-09-15 (0001193125-26-391415), split 4.
| Tool | Figure | Cites | Source has it | As-of | Links went to |
|---|---|---|---|---|---|
| Signal8 Octo | yes | yes | no | yes | SEC filing |
| Claude | yes | yes | yes | yes | SEC filing and other sites |
| ChatGPT | yes | yes | yes | yes | SEC filing and other sites |
| AskEdgar Studio | yes | no | no | yes | no link captured |
| Perplexity second blind pass | yes | yes | yes | yes | SEC filing and other sites |
| Gemini second blind pass | yes | no | no | yes | Not measured |
R3-08 · Cash and runway · SEGG
Using only reports Sports Entertainment Gaming Global (SEGG) had filed with the SEC on or before October 31, 2026: what was its most recently reported quarter-end cash and cash equivalents, and for which balance-sheet date?
Sealed key: $785,905 at March 31, 2026 (Q1 2026 Form 10-Q, filed October 8, 2026). The Q2 2026 10-Q was not filed until November 2, 2026. As of: March 31, 2026 balance; reports filed on or before October 31, 2026.
Filings in the key: 10-Q filed 2026-10-08 (0001493152-26-046279), Q1 2026 10-Q.
| Tool | Figure | Cites | Source has it | As-of | Links went to |
|---|---|---|---|---|---|
| Signal8 Octo | yes | yes | yes | yes | SEC filing |
| Claude | yes | yes | yes | yes | SEC filing and other sites |
| ChatGPT | yes | yes | yes | yes | no link captured |
| AskEdgar Studio | yes | yes | yes | yes | no link captured |
| Perplexity second blind pass | yes | yes | yes | yes | other sites only |
| Gemini second blind pass | yes | no | no | yes | Not measured |
R3-09 · Shares and float · SURG
In the most recent Form 10-Q that SurgePays (SURG) had filed on or before October 31, 2026, how many shares of common stock were outstanding as of the cover-page date, and how many were issued and outstanding on the balance sheet at the end of the quarter?
Sealed key: Cover: 52,908,423 shares outstanding as of August 19, 2026. Balance sheet: 26,511,665 shares at June 30, 2026 (10-Q for the quarter ended June 30, 2026). As of: Cover date August 19, 2026; balance sheet June 30, 2026.
Filings in the key: 10-Q filed 2026-08-19 (0001493152-26-039250), Q2 2026 10-Q.
| Tool | Figure | Cites | Source has it | As-of | Links went to |
|---|---|---|---|---|---|
| Signal8 Octo | yes | yes | yes | yes | SEC filing |
| Claude | yes | yes | yes | yes | SEC filing and other sites |
| ChatGPT | yes | yes | yes | yes | SEC filing |
| AskEdgar Studio | yes | yes | yes | yes | no link captured |
| Perplexity second blind pass | no | yes | no | no | SEC filing |
| Gemini second blind pass | yes | yes | yes | yes | Not measured |
R3-10 · Nasdaq status (8-K) · BFRG
As of October 31, 2026, by what date did Bullfrog AI Holdings (BFRG) have to regain compliance with Nasdaq's $1.00 minimum bid price requirement?
Sealed key: February 8, 2027 (second 180-calendar-day compliance period granted August 18, 2026; the initial period ran to August 10, 2026). As of: October 31, 2026.
Filings in the key: 8-K filed 2026-08-20 (0001628280-26-058143), extension 8-K.
| Tool | Figure | Cites | Source has it | As-of | Links went to |
|---|---|---|---|---|---|
| Signal8 Octo | yes | yes | yes | yes | SEC filing |
| Claude | yes | yes | yes | yes | other sites only |
| ChatGPT | yes | yes | yes | no | no link captured |
| AskEdgar Studio | yes | no | no | yes | no link captured |
| Perplexity second blind pass | yes | yes | yes | yes | SEC filing |
| Gemini second blind pass | yes | no | no | yes | Not measured |
R3-11 · ATM, warrants or shelf · ECOR
As of September 30, 2026, how much remained available under electroCore's (ECOR) at-the-market sales agreement with H.C. Wainwright, and how much remained for potential issuance under its 2025 shelf registration overall?
Sealed key: $15.7 million under the Sales Agreement (originally up to $20.0 million, entered November 29, 2024), within $95.9 million remaining under the 2025 shelf registration statement (File No. 333-284477). As of: September 30, 2026.
Filings in the key: 10-Q filed 2026-11-04 (0001493152-26-049961), Q3 2026 10-Q.
| Tool | Figure | Cites | Source has it | As-of | Links went to |
|---|---|---|---|---|---|
| Signal8 Octo | yes | yes | yes | yes | SEC filing |
| Claude | yes | yes | yes | yes | SEC filing |
| ChatGPT | yes | yes | yes | yes | SEC filing |
| AskEdgar Studio | yes | yes | yes | yes | no link captured |
| Perplexity second blind pass | yes | yes | yes | yes | SEC filing |
| Gemini second blind pass | yes | yes | yes | yes | Not measured |
R3-12 · Reverse splits · IVF
Between January 1, 2025 and October 15, 2026, how many reverse stock splits did INVO Fertility (IVF) make effective, and what is the cumulative reverse-split factor?
Sealed key: Four: 1-for-12 (effective March 18, 2025), 1-for-3 (July 21, 2025), 1-for-8 (November 28, 2025) and 1-for-5 (March 27, 2026). Cumulative factor 12 x 3 x 8 x 5 = 1,440. As of: Window January 1, 2025 to October 15, 2026.
Filings in the key: 8-K filed 2025-03-24 (0001641172-25-000316), split 1; 8-K filed 2025-07-21 (0001641172-25-020406), split 2; 8-K filed 2025-12-03 (0001493152-25-025977), split 3; 8-K filed 2026-03-31 (0001493152-26-014227), split 4; 8-K filed 2026-11-04 (0001493152-26-049991), trap: outside window.
| Tool | Figure | Cites | Source has it | As-of | Links went to |
|---|---|---|---|---|---|
| Signal8 Octo | yes | yes | no | yes | SEC filing |
| Claude | yes | yes | no | yes | SEC filing and other sites |
| ChatGPT | yes | no | no | yes | no link captured |
| AskEdgar Studio | no | no | no | yes | no link captured |
| Perplexity second blind pass | no | yes | no | yes | SEC filing and other sites |
| Gemini second blind pass | yes | no | no | yes | Not measured |
R3-13 · Cash and runway · CELU
Using only reports Celularity (CELU) had filed on or before October 15, 2026: what were its most recently reported quarter-end cash and cash equivalents on the balance sheet (excluding restricted cash), and the balance-sheet date?
Sealed key: $368 thousand at March 31, 2026 (Q1 2026 Form 10-Q filed September 29, 2026). Cash, cash equivalents and restricted cash totalled $10.477 million, of which $10.109 million was non-current restricted cash. As of: March 31, 2026 balance; reports filed on or before October 15, 2026.
Filings in the key: 10-Q filed 2026-09-29 (0001493152-26-044892), Q1 2026 10-Q.
| Tool | Figure | Cites | Source has it | As-of | Links went to |
|---|---|---|---|---|---|
| Signal8 Octo | yes | yes | yes | yes | SEC filing |
| Claude | yes | yes | yes | yes | SEC filing and other sites |
| ChatGPT | yes | yes | yes | yes | no link captured |
| AskEdgar Studio | yes | yes | yes | yes | no link captured |
| Perplexity second blind pass | yes | yes | yes | yes | SEC filing |
| Gemini second blind pass | yes | yes | yes | yes | Not measured |
R3-14 · Shares and float · MITI
In the most recent Form 10-Q that Mitesco (MITI) had filed on or before October 31, 2026, how many shares of common stock were outstanding as of the cover-page date, and how many were issued and outstanding on the balance sheet at the end of the quarter?
Sealed key: Cover: 48,392,796 shares outstanding as of August 17, 2026. Balance sheet: 20,940,597 shares at June 30, 2026 (10-Q for the quarter ended June 30, 2026). As of: Cover date August 17, 2026; balance sheet June 30, 2026.
Filings in the key: 10-Q filed 2026-08-17 (0001185185-26-003575), Q2 2026 10-Q.
| Tool | Figure | Cites | Source has it | As-of | Links went to |
|---|---|---|---|---|---|
| Signal8 Octo | yes | yes | yes | yes | SEC filing |
| Claude | yes | yes | yes | yes | SEC filing and other sites |
| ChatGPT | yes | yes | yes | yes | SEC filing |
| AskEdgar Studio | yes | yes | yes | yes | no link captured |
| Perplexity | No answer recorded | ||||
| Gemini second blind pass | yes | yes | yes | yes | Not measured |
R3-15 · Amended filing · NUAI
What was New Era Energy & Digital's (NUAI) net loss for the three months ended March 31, 2026, as currently reported after any amendment filed on or before October 31, 2026?
Sealed key: $10,823,974 (as restated in the Form 10-Q/A filed August 14, 2026); originally reported as $8,991,887. Net loss per share $(0.19) restated vs $(0.16). As of: Quarter ended March 31, 2026; amendments through October 31, 2026.
Filings in the key: 10-Q/A filed 2026-08-14 (0001213900-26-090122), 10-Q/A; 10-Q filed 2026-05-15 (0001213900-26-057022), trap: original 10-Q.
| Tool | Figure | Cites | Source has it | As-of | Links went to |
|---|---|---|---|---|---|
| Signal8 Octo | yes | yes | yes | yes | SEC filing |
| Claude | yes | yes | yes | yes | SEC filing and other sites |
| ChatGPT | yes | yes | yes | yes | SEC filing |
| AskEdgar Studio | yes | yes | yes | yes | SEC filing |
| Perplexity second blind pass | yes | yes | yes | yes | SEC filing |
| Gemini second blind pass | yes | yes | yes | yes | Not measured |
R3-16 · ATM, warrants or shelf · VTGN
As of June 30, 2026, what was the total size of Vistagen Therapeutics' (VTGN) at-the-market sales agreement and how much remained available under it?
Sealed key: Up to $175 million in total; approximately $139.5 million remained available at June 30, 2026 (first quarter of fiscal 2027). 1,580,176 shares were sold under it in the quarter. As of: June 30, 2026.
Filings in the key: 10-Q filed 2026-08-14 (0001628280-26-057116), 10-Q for quarter ended June 30, 2026.
| Tool | Figure | Cites | Source has it | As-of | Links went to |
|---|---|---|---|---|---|
| Signal8 Octo | yes | yes | yes | yes | SEC filing |
| Claude | yes | yes | no | yes | other sites only |
| ChatGPT | yes | yes | yes | yes | no link captured |
| AskEdgar Studio | yes | yes | yes | yes | no link captured |
| Perplexity second blind pass | no | yes | no | yes | other sites only |
| Gemini second blind pass | no | yes | no | yes | Not measured |
R3-17 · Reverse splits · NVVE
Nuvve Holding (NVVE) reported 2,069,840 shares of common stock outstanding at December 31, 2025 in its FY2025 Form 10-K. As retroactively restated in its later 2026 quarterly reports for the reverse split it effected in 2026, how many shares were outstanding at December 31, 2025, and what was the split ratio and effective date?
Sealed key: 114,991 shares outstanding (114,993 issued) at December 31, 2025, after the 1-for-18 reverse split effective July 6, 2026. As of: December 31, 2025 balance, as restated in the 10-Q for the quarter ended March 31, 2026 (filed July 15, 2026).
Filings in the key: 10-K filed 2026-03-31 (0001836875-26-000026), original figure; 10-Q filed 2026-07-15 (0001836875-26-000059), restated figure; 8-K filed 2026-07-01 (0001836875-26-000051), split 8-K.
| Tool | Figure | Cites | Source has it | As-of | Links went to |
|---|---|---|---|---|---|
| Signal8 Octo | yes | yes | yes | yes | SEC filing |
| Claude | yes | yes | yes | yes | SEC filing and other sites |
| ChatGPT | yes | yes | yes | yes | SEC filing |
| AskEdgar Studio | yes | yes | yes | yes | no link captured |
| Perplexity second blind pass | yes | yes | yes | yes | SEC filing and other sites |
| Gemini second blind pass | yes | no | no | yes | Not measured |
R3-18 · Cash and runway · XTIA
Using only reports XTI Aerospace (XTIA) had filed on or before October 15, 2026: what was its most recently reported quarter-end cash and cash equivalents, and for which date?
Sealed key: $15.185 million at March 31, 2026 (Q1 2026 Form 10-Q filed May 14, 2026). The Q2 2026 10-Q was not filed until October 20, 2026. As of: March 31, 2026 balance; reports filed on or before October 15, 2026.
Filings in the key: 10-Q filed 2026-05-14 (0001213900-26-056270), Q1 2026 10-Q.
| Tool | Figure | Cites | Source has it | As-of | Links went to |
|---|---|---|---|---|---|
| Signal8 Octo | yes | yes | yes | yes | SEC filing |
| Claude | yes | yes | yes | yes | SEC filing and other sites |
| ChatGPT | yes | yes | yes | yes | no link captured |
| AskEdgar Studio | yes | yes | yes | yes | SEC filing |
| Perplexity second blind pass | yes | yes | yes | yes | SEC filing |
| Gemini second blind pass | yes | yes | yes | yes | Not measured |
R3-19 · Shares and float · YHC
In the most recent Form 10-Q that LQR House (YHC) had filed on or before October 31, 2026, how many shares of common stock were outstanding as of the cover-page date, and how many were issued and outstanding on the balance sheet at the end of the quarter?
Sealed key: Cover: 1,303,857 shares outstanding as of August 19, 2026. Balance sheet: 215,335 shares at June 30, 2026 (10-Q for the quarter ended June 30, 2026). As of: Cover date August 19, 2026; balance sheet June 30, 2026.
Filings in the key: 10-Q filed 2026-08-19 (0001213900-26-091661), Q2 2026 10-Q.
| Tool | Figure | Cites | Source has it | As-of | Links went to |
|---|---|---|---|---|---|
| Signal8 Octo | yes | yes | yes | yes | SEC filing |
| Claude | yes | yes | yes | yes | SEC filing |
| ChatGPT | yes | yes | yes | yes | SEC filing |
| AskEdgar Studio | yes | yes | yes | yes | SEC filing |
| Perplexity second blind pass | yes | yes | yes | yes | SEC filing and other sites |
| Gemini second blind pass | yes | yes | yes | yes | Not measured |
R3-20 · Amended filing · RR
What was Richtech Robotics' (RR) consolidated net loss for the fiscal year ended September 30, 2025, as currently reported after any restatement filed on or before October 31, 2026?
Sealed key: $49.182 million (as restated in the Form 10-K/A filed August 7, 2026); originally reported as $15.754 million. As of: Fiscal year ended September 30, 2025; amendments through October 31, 2026.
Filings in the key: 10-K/A filed 2026-08-07 (0001213900-26-086751), 10-K/A.
| Tool | Figure | Cites | Source has it | As-of | Links went to |
|---|---|---|---|---|---|
| Signal8 Octo | yes | yes | yes | yes | SEC filing |
| Claude | yes | yes | yes | yes | SEC filing and other sites |
| ChatGPT | yes | yes | yes | yes | no link captured |
| AskEdgar Studio | yes | yes | yes | yes | no link captured |
| Perplexity second blind pass | yes | yes | yes | yes | SEC filing |
| Gemini second blind pass | yes | yes | yes | yes | Not measured |
R3-21 · ATM, warrants or shelf · DCOY
As of September 30, 2026, what was the exercise price of the Series A and Series C Milestone Warrants that Decoy Therapeutics (DCOY) issued on June 29, 2026, and what happened to the Series B Milestone Warrants?
Sealed key: $3.25 per share, reduced from the original $5.91 in the September 22, 2026 inducement. The Series B Milestone Warrants (1,184,434 shares) were exercised in full for cash at the reduced $3.25, and Decoy issued new warrants for 2,368,868 shares at $3.25. As of: September 30, 2026.
Filings in the key: 8-K filed 2026-06-29 (0001193125-26-286737), original terms; 8-K filed 2026-09-23 (0001615219-26-000019), inducement 8-K.
| Tool | Figure | Cites | Source has it | As-of | Links went to |
|---|---|---|---|---|---|
| Signal8 Octo | yes | yes | yes | yes | SEC filing |
| Claude | yes | yes | yes | yes | SEC filing and other sites |
| ChatGPT | yes | yes | yes | yes | no link captured |
| AskEdgar Studio | yes | yes | yes | yes | no link captured |
| Perplexity second blind pass | yes | yes | yes | yes | SEC filing |
| Gemini second blind pass | yes | no | no | yes | Not measured |
R3-22 · Reverse splits · KITT
Nauticus Robotics (KITT) reported 28,811,198 shares of common stock outstanding at December 31, 2025 in its FY2025 Form 10-K (filed April 15, 2026). Adjusted for every reverse stock split it effected after that filing and on or before October 31, 2026, what is the equivalent share count, and which splits apply?
Sealed key: About 600,233 shares: the 1-for-8 split (effective April 17, 2026; 10-Qs restate the figure as 3,601,400) and the 1-for-6 split (effective September 24, 2026) give a combined factor of 48; 28,811,198 / 48 = 600,233.3 (3,601,400 / 6 = 600,233.3). As of: Splits effective after April 15, 2026 and on or before October 31, 2026.
Correction: the 8-K gives the 1-for-8 split's effective date as April 21, 2026; April 17 was the announcement. Graders credited April 21. No score changed.
Filings in the key: 10-K filed 2026-04-15 (0001849820-26-000051), original figure; 8-K filed 2026-04-17 (0001849820-26-000057), split 1; 10-Q filed 2026-05-14 (0001849820-26-000090), restated for split 1; 8-K filed 2026-09-23 (0001849820-26-000142), split 2.
| Tool | Figure | Cites | Source has it | As-of | Links went to |
|---|---|---|---|---|---|
| Signal8 Octo | yes | yes | yes | yes | SEC filing |
| Claude | yes | yes | yes | yes | SEC filing and other sites |
| ChatGPT | yes | yes | yes | yes | no link captured |
| AskEdgar Studio | yes | no | no | yes | no link captured |
| Perplexity second blind pass | yes | yes | yes | yes | SEC filing |
| Gemini second blind pass | yes | no | no | yes | Not measured |
R3-23 · Cash and runway · TELO
Based on the most recent quarterly report Telomir Pharmaceuticals (TELO) had filed on or before November 10, 2026: what were its cash and cash equivalents at quarter end, and through when did management say its cash would fund operations?
Sealed key: approximately $4.5 million ($4,515,704) at September 30, 2026 (10-Q for the quarter ended September 30, 2026); management expects it to fund operations into the fourth quarter of 2027. The prior quarter's 10-Q had said through the first quarter of 2027. As of: September 30, 2026; reports filed on or before November 10, 2026.
Filings in the key: 10-Q filed 2026-11-06 (0001493152-26-050489), Q3 2026 10-Q; 10-Q filed 2026-08-13 (0001493152-26-037854), trap: superseded Q2 guidance.
| Tool | Figure | Cites | Source has it | As-of | Links went to |
|---|---|---|---|---|---|
| Signal8 Octo | yes | yes | yes | yes | SEC filing |
| Claude | yes | yes | yes | yes | SEC filing |
| ChatGPT | yes | yes | yes | yes | SEC filing |
| AskEdgar Studio | yes | yes | yes | yes | SEC filing |
| Perplexity second blind pass | yes | yes | yes | yes | other sites only |
| Gemini second blind pass | no | yes | no | yes | Not measured |
R3-24 · Shares and float · HLSQ
In the most recent Form 10-Q that BiomX, Inc. (now Tessera Defense & Homeland Security) (HLSQ) had filed on or before October 31, 2026, how many shares of common stock were outstanding as of the cover-page date, and how many were issued and outstanding on the balance sheet at the end of the quarter?
Sealed key: Cover: 26,723,870 shares outstanding as of August 18, 2026. Balance sheet: 12,590,641 shares at June 30, 2026 (10-Q for the quarter ended June 30, 2026). As of: Cover date August 18, 2026; balance sheet June 30, 2026.
Filings in the key: 10-Q filed 2026-08-19 (0001213900-26-091780), Q2 2026 10-Q.
| Tool | Figure | Cites | Source has it | As-of | Links went to |
|---|---|---|---|---|---|
| Signal8 Octo | yes | yes | yes | yes | SEC filing |
| Claude | yes | yes | yes | yes | other sites only |
| ChatGPT | yes | yes | yes | yes | SEC filing |
| AskEdgar Studio | yes | yes | yes | yes | no link captured |
| Perplexity second blind pass | yes | yes | yes | yes | SEC filing |
| Gemini second blind pass | no | yes | no | no | Not measured |
R3-25 · Amended filing · ROLR
What was High Roller Technologies' (ROLR) net loss for the six months ended June 30, 2026, as currently reported after any amendment filed on or before October 31, 2026?
Sealed key: $4.333 million (as restated in the Form 10-Q/A filed October 16, 2026); originally reported as $5.336 million. As of: Six months ended June 30, 2026; amendments through October 31, 2026.
Filings in the key: 10-Q/A filed 2026-10-16 (0001753926-26-001960), 10-Q/A; 10-Q filed 2026-08-11 (0001753926-26-001419), trap: original 10-Q.
| Tool | Figure | Cites | Source has it | As-of | Links went to |
|---|---|---|---|---|---|
| Signal8 Octo | yes | yes | yes | yes | SEC filing |
| Claude | yes | yes | yes | yes | SEC filing and other sites |
| ChatGPT | yes | yes | yes | yes | no link captured |
| AskEdgar Studio | yes | yes | yes | yes | no link captured |
| Perplexity second blind pass | yes | yes | yes | yes | other sites only |
| Gemini second blind pass | yes | yes | yes | yes | Not measured |
R3-26 · ATM, warrants or shelf · WWR
As of June 30, 2026, how much equity capacity did Westwater Resources (WWR) have remaining under its ATM sales agreement and under its Lincoln Park purchase agreement, respectively?
Sealed key: Approximately $70.6 million remaining under the ATM Sales Agreement and approximately $26.2 million under the 2024 Lincoln Park purchase agreement. As of: June 30, 2026.
Filings in the key: 10-Q filed 2026-08-10 (0001104659-26-092955), Q2 2026 10-Q.
| Tool | Figure | Cites | Source has it | As-of | Links went to |
|---|---|---|---|---|---|
| Signal8 Octo | yes | yes | yes | yes | SEC filing |
| Claude | yes | yes | yes | yes | other sites only |
| ChatGPT | yes | yes | yes | yes | other sites only |
| AskEdgar Studio | yes | yes | yes | yes | no link captured |
| Perplexity second blind pass | yes | yes | yes | yes | SEC filing |
| Gemini second blind pass | yes | yes | yes | yes | Not measured |
R3-27 · Reverse splits · SLXN
Between January 1, 2024 and October 31, 2026, how many reverse share splits did Silexion Therapeutics (SLXN) effect, at what ratios, and what is the cumulative factor?
Sealed key: Three: 1-for-9 (November 2024), 1-for-15 (July 2025) and 1-for-10 (effective after the close on May 28, 2026). Cumulative factor 9 x 15 x 10 = 1,350. As of: Window January 1, 2024 to October 31, 2026.
Filings in the key: 8-K filed 2026-08-13 (0001178913-26-004128), three splits summarised; 8-K filed 2026-05-29 (0001178913-26-002988), split 3 8-K; 8-K filed 2026-11-09 (0001178913-26-005089), trap: outside window.
| Tool | Figure | Cites | Source has it | As-of | Links went to |
|---|---|---|---|---|---|
| Signal8 Octo | yes | yes | no | yes | SEC filing |
| Claude | yes | yes | no | yes | SEC filing and other sites |
| ChatGPT | yes | no | no | yes | no link captured |
| AskEdgar Studio | yes | no | no | yes | no link captured |
| Perplexity second blind pass | yes | no | no | yes | no link captured |
| Gemini second blind pass | yes | no | no | yes | Not measured |
R3-28 · Cash and runway · ALGS
Based on the most recent quarterly report Aligos Therapeutics (ALGS) had filed on or before November 10, 2026: what were its cash and cash equivalents at quarter end, and through when did management say its cash would fund operations?
Sealed key: $31.1 million at September 30, 2026 (10-Q for the quarter ended September 30, 2026); management expects it to fund operations into the first quarter of 2027. The prior quarter's 10-Q had said into the fourth quarter of 2026. As of: September 30, 2026; reports filed on or before November 10, 2026.
Filings in the key: 10-Q filed 2026-11-06 (0001193125-26-450798), Q3 2026 10-Q; 10-Q filed 2026-08-06 (0001193125-26-336851), trap: superseded Q2 guidance.
| Tool | Figure | Cites | Source has it | As-of | Links went to |
|---|---|---|---|---|---|
| Signal8 Octo | yes | yes | yes | yes | SEC filing |
| Claude | yes | yes | yes | yes | other sites only |
| ChatGPT | yes | yes | yes | yes | SEC filing |
| AskEdgar Studio | yes | yes | yes | yes | SEC filing |
| Perplexity second blind pass | yes | yes | yes | yes | SEC filing and other sites |
| Gemini second blind pass | yes | yes | yes | yes | Not measured |
R3-29 · Shares and float · SGLY
According to the most recent annual report Singularity Future Technology (SGLY) had filed as of October 31, 2026, what was the aggregate market value of its common stock held by non-affiliates, and as of what date was it measured?
Sealed key: Approximately $4,600,110 as of December 31, 2025 (cover of the Form 10-K for the fiscal year ended June 30, 2026, filed September 29, 2026). As of: December 31, 2025 (last business day of second fiscal quarter).
Filings in the key: 10-K filed 2026-09-29 (0001213900-26-104650), FY2026 10-K.
| Tool | Figure | Cites | Source has it | As-of | Links went to |
|---|---|---|---|---|---|
| Signal8 Octo | yes | yes | yes | yes | SEC filing |
| Claude | yes | yes | yes | yes | SEC filing and other sites |
| ChatGPT | yes | yes | yes | yes | SEC filing |
| AskEdgar Studio | no | yes | no | no | SEC filing |
| Perplexity second blind pass | yes | yes | yes | yes | SEC filing |
| Gemini | No answer recorded (free usage limit) | ||||
R3-30 · Nasdaq status (8-K) · CISO
As of October 31, 2026, by what date did CISO Global (CISO) have to regain compliance with Nasdaq's $1.00 minimum bid price requirement?
Sealed key: December 28, 2026 (second 180-day compliance period granted June 30, 2026; the first period ran to June 29, 2026). As of: October 31, 2026.
Filings in the key: 8-K filed 2026-07-06 (0001493152-26-032157), extension 8-K.
| Tool | Figure | Cites | Source has it | As-of | Links went to |
|---|---|---|---|---|---|
| Signal8 Octo | yes | yes | yes | yes | SEC filing |
| Claude | yes | yes | no | yes | other sites only |
| ChatGPT | yes | yes | yes | yes | no link captured |
| AskEdgar Studio | yes | no | no | yes | no link captured |
| Perplexity second blind pass | yes | yes | yes | yes | SEC filing |
| Gemini | No answer recorded (free usage limit) | ||||
R3-31 · ATM, warrants or shelf · EZRA
According to the most recent quarterly report Reliance Global Group (EZRA) had filed on or before October 31, 2026, how much remained available under its ATM program as of the latest date that report discloses, and how much had remained at quarter end?
Sealed key: Approximately $456,000 after a further 74,251 shares were sold after June 30, 2026 (net proceeds about $167,000); at June 30, 2026 approximately $632,000 remained. As of: Latest date disclosed in the 10-Q for the quarter ended June 30, 2026 (filed July 30, 2026).
Filings in the key: 10-Q filed 2026-07-30 (0001493152-26-035504), Q2 2026 10-Q.
| Tool | Figure | Cites | Source has it | As-of | Links went to |
|---|---|---|---|---|---|
| Signal8 Octo | yes | yes | yes | yes | SEC filing |
| Claude | yes | yes | yes | yes | SEC filing and other sites |
| ChatGPT | yes | yes | yes | yes | SEC filing |
| AskEdgar Studio | yes | yes | yes | yes | SEC filing |
| Perplexity second blind pass | yes | yes | yes | yes | SEC filing |
| Gemini | No answer recorded (free usage limit) | ||||
R3-32 · Reverse splits · NXXT
How many reverse stock splits did NextNRG (NXXT) make effective between January 1, 2026 and October 31, 2026, and what is the cumulative factor?
Sealed key: Two: 1-for-10 effective September 14, 2026 and another 1-for-10 effective October 30, 2026. Cumulative factor 100 (1-for-100). As of: Window January 1, 2026 to October 31, 2026.
Filings in the key: 8-K filed 2026-09-14 (0001493152-26-042576), split 1; 8-K filed 2026-10-30 (0001493152-26-049449), split 2; 8-K filed 2026-11-06 (0001493152-26-050459), confirmation.
| Tool | Figure | Cites | Source has it | As-of | Links went to |
|---|---|---|---|---|---|
| Signal8 Octo | yes | yes | yes | yes | SEC filing |
| Claude | yes | yes | yes | yes | SEC filing and other sites |
| ChatGPT | yes | no | no | yes | no link captured |
| AskEdgar Studio | yes | no | no | yes | no link captured |
| Perplexity second blind pass | yes | yes | yes | yes | SEC filing |
| Gemini | No answer recorded (free usage limit) | ||||
R3-33 · Cash and runway · ELTX
Based on the most recent quarterly report Elicio Therapeutics (ELTX) had filed on or before November 10, 2026: what were its cash and cash equivalents at quarter end, and through when did management say its cash would fund operations?
Sealed key: $30.9 million at September 30, 2026 (10-Q for the quarter ended September 30, 2026); management expects it to fund operations into the second quarter of 2027. The prior quarter's 10-Q had said into the first quarter of 2027. As of: September 30, 2026; reports filed on or before November 10, 2026.
Filings in the key: 10-Q filed 2026-11-05 (0001601485-26-000066), Q3 2026 10-Q; 10-Q filed 2026-08-13 (0001601485-26-000056), trap: superseded Q2 guidance.
| Tool | Figure | Cites | Source has it | As-of | Links went to |
|---|---|---|---|---|---|
| Signal8 Octo | yes | yes | yes | yes | SEC filing |
| Claude | yes | yes | yes | yes | SEC filing and other sites |
| ChatGPT | yes | yes | yes | yes | SEC filing and other sites |
| AskEdgar Studio | yes | yes | yes | yes | no link captured |
| Perplexity second blind pass | yes | yes | yes | yes | no link captured |
| Gemini | No answer recorded (free usage limit) | ||||
R3-34 · Shares and float · NAII
According to the most recent annual report Natural Alternatives International (NAII) had filed as of October 31, 2026: what was the aggregate market value of common stock held by non-affiliates (and at what date), and how many shares were outstanding on the cover date?
Sealed key: Approximately $22,113,000 as of December 31, 2025 (based on a $3.58 close); 6,264,847 shares outstanding as of September 28, 2026, net of 3,387,059 treasury shares (Form 10-K for fiscal year ended June 30, 2026, filed September 28, 2026). As of: Float December 31, 2025; shares September 28, 2026.
Filings in the key: 10-K filed 2026-09-28 (0001437749-26-031343), FY2026 10-K.
| Tool | Figure | Cites | Source has it | As-of | Links went to |
|---|---|---|---|---|---|
| Signal8 Octo | yes | yes | yes | yes | SEC filing |
| Claude | yes | yes | yes | yes | SEC filing |
| ChatGPT | yes | yes | yes | yes | SEC filing |
| AskEdgar Studio | yes | yes | yes | yes | SEC filing |
| Perplexity second blind pass | yes | yes | yes | yes | SEC filing |
| Gemini | No answer recorded (free usage limit) | ||||
R3-35 · Insider purchases (Form 4) · HEPA
On August 3, 2026, Hepion Pharmaceuticals (HEPA) insiders reported open-market purchases (Form 4 code P). In total, how many common shares did they buy, at what price, and what else did they acquire alongside the shares?
Sealed key: 16,500,000 common shares at $0.05 (about $825,000) across five reporting persons: LoPriore (Executive Chairman) 10,000,000 indirect (8,000,000 + 2,000,000), CEO Appajosyula 2,000,000, CFO Stetz 2,000,000, director Purcell 2,000,000 and director Stetz II 500,000. Each also received an equal number of warrants (16,500,000 in total) exercisable at $0.06, expiring August 3, 2031. As of: Transaction date August 3, 2026 (Form 4s filed August 12, 2026).
Filings in the key: 4 filed 2026-08-12 (0001493152-26-037489), Form 4 LoPriore; 4 filed 2026-08-12 (0001493152-26-037490), Form 4 Appajosyula; 4 filed 2026-08-12 (0001493152-26-037493), Form 4 Purcell; 4 filed 2026-08-12 (0001493152-26-037496), Form 4 Stetz; 4 filed 2026-08-12 (0001493152-26-037500), Form 4 Stetz II.
| Tool | Figure | Cites | Source has it | As-of | Links went to |
|---|---|---|---|---|---|
| Signal8 Octo | yes | yes | yes | yes | SEC filing |
| Claude | yes | yes | yes | yes | SEC filing and other sites |
| ChatGPT | yes | no | no | yes | no link captured |
| AskEdgar Studio | no | yes | no | yes | SEC filing |
| Perplexity second blind pass | yes | yes | no | yes | other sites only |
| Gemini | No answer recorded (free usage limit) | ||||
R3-36 · Reverse splits · PFSA
Profusa (PFSA) reported 1,232,052 shares of common stock issued and outstanding at December 31, 2025 in its FY2025 Form 10-K. After the reverse splits it effected later in 2026, what is that December 31, 2025 figure as restated in its later quarterly report, and which splits caused the change?
Sealed key: 12,320 shares (10-Q for the quarter ended June 30, 2026), reflecting the 1-for-25 split (July 2026) and the 1-for-4 split (August 2026), a combined factor of 100. The February 9, 2026 1-for-75 split is already reflected in the 10-K figure. As of: December 31, 2025 balance as restated in the 10-Q filed August 19, 2026.
Filings in the key: 10-K filed 2026-04-15 (0001213900-26-044046), original figure; 8-K filed 2026-07-06 (0001213900-26-075502), split 2; 8-K filed 2026-08-14 (0001213900-26-089362), split 3; 10-Q filed 2026-08-19 (0001213900-26-091696), restated figure.
| Tool | Figure | Cites | Source has it | As-of | Links went to |
|---|---|---|---|---|---|
| Signal8 Octo | yes | yes | yes | yes | SEC filing |
| Claude | yes | yes | yes | yes | SEC filing and other sites |
| ChatGPT | no | no | no | no | no link captured |
| AskEdgar Studio | yes | yes | yes | yes | no link captured |
| Perplexity second blind pass | no | yes | no | yes | SEC filing |
| Gemini | No answer recorded (free usage limit) | ||||
R3-37 · Cash and runway · NXTC
Based on the most recent quarterly report NextCure (NXTC) had filed on or before November 10, 2026: what were its cash and cash equivalents at quarter end, and through when did management say its cash would fund operations?
Sealed key: $8.7 million at September 30, 2026 (10-Q for the quarter ended September 30, 2026); management expects it to fund operations into early 2027. The prior quarter's 10-Q had said into the fourth quarter of 2026. As of: September 30, 2026; reports filed on or before November 10, 2026.
Filings in the key: 10-Q filed 2026-11-10 (0001104659-26-125220), Q3 2026 10-Q; 10-Q filed 2026-08-06 (0001104659-26-092050), trap: superseded Q2 guidance.
| Tool | Figure | Cites | Source has it | As-of | Links went to |
|---|---|---|---|---|---|
| Signal8 Octo | yes | yes | yes | yes | SEC filing |
| Claude | yes | yes | yes | yes | SEC filing and other sites |
| ChatGPT | yes | yes | yes | yes | other sites only |
| AskEdgar Studio | yes | yes | yes | yes | SEC filing |
| Perplexity second blind pass | yes | yes | yes | yes | SEC filing and other sites |
| Gemini | No answer recorded (free usage limit) | ||||
R3-38 · Shares and float · TGL
According to the most recent annual report Treasure Global (TGL) had filed as of October 31, 2026: what was the aggregate market value of common stock held by non-affiliates (and at what date), and how many shares were outstanding on the cover date?
Sealed key: Approximately $10.1 million as of December 31, 2025 (based on a $6.13 close); 5,159,897 shares outstanding on October 13, 2026 (Form 10-K for fiscal year ended June 30, 2026). As of: Float December 31, 2025; shares October 13, 2026.
Filings in the key: 10-K filed 2026-10-13 (0001213900-26-109073), FY2026 10-K.
| Tool | Figure | Cites | Source has it | As-of | Links went to |
|---|---|---|---|---|---|
| Signal8 Octo | yes | yes | yes | yes | SEC filing |
| Claude | yes | yes | yes | yes | SEC filing and other sites |
| ChatGPT | yes | yes | yes | yes | SEC filing |
| AskEdgar Studio | yes | yes | yes | yes | no link captured |
| Perplexity second blind pass | no | yes | no | yes | other sites only |
| Gemini | No answer recorded (free usage limit) | ||||
R3-39 · Insider purchases (Form 4) · PMTS
On September 14, 2026, what was the total number of CPI Card Group (PMTS) shares that insiders reported BUYING on Form 4 (code P), at what price, and how many shares did selling stockholder Parallel49 Equity report selling that day?
Sealed key: 556,232 shares bought at $21.50 by five reporting persons (Tricor PMT25 Holdings 525,000; H Sanford Riley 13,953; Nicholas Peters 11,628 indirect; Marc Sheinbaum 4,651; Ravi Mallela 1,000). Parallel49 Equity, ULC reported selling 2,687,921 shares at $20.425 under the September 10, 2026 underwriting agreement. As of: Transaction date September 14, 2026.
Filings in the key: 4 filed 2026-09-14 (0001104659-26-107610), Form 4 Tricor PMT25; 4 filed 2026-09-14 (0001317406-26-000006), Form 4 Riley; 4 filed 2026-09-14 (0001654770-26-000004), Form 4 Peters; 4 filed 2026-09-14 (0001605873-26-000004), Form 4 Sheinbaum; 4 filed 2026-09-14 (0001751947-26-000004), Form 4 Mallela; 4 filed 2026-09-14 (0001655148-26-000004), Form 4 Parallel49 (sale).
| Tool | Figure | Cites | Source has it | As-of | Links went to |
|---|---|---|---|---|---|
| Signal8 Octo | yes | yes | yes | yes | no link captured |
| Claude | yes | yes | yes | yes | SEC filing and other sites |
| ChatGPT | yes | yes | yes | yes | no link captured |
| AskEdgar Studio | no | yes | no | yes | no link captured |
| Perplexity second blind pass | yes | yes | no | yes | other sites only |
| Gemini | No answer recorded (free usage limit) | ||||
R3-40 · Insider purchases (Form 4) · INV
On August 20, 2026, several Innventure (INV) insiders reported open-market purchases on Form 4. How many shares did they buy in total, what was the total reported cost, and what overall per-share price range do the Form 4 footnotes disclose?
Sealed key: 536,000 shares across four reporting persons (Michael Otworth 231,000 @ $1.5121; James O. Donnally 225,000 @ $1.50, indirect via Our-No Family Holdings; Gregory W. Haskell 50,000 @ $1.512; Bruce Brown 30,000 @ $1.5133). Total about $807,794. The reported prices are weighted averages; footnotes give individual fills from $1.46 to $1.59. As of: Transaction date August 20, 2026 (Form 4s filed August 21, 2026).
Filings in the key: 4 filed 2026-08-21 (0001628280-26-058332), Form 4 Otworth; 4 filed 2026-08-21 (0001628280-26-058331), Form 4 Donnally; 4 filed 2026-08-21 (0001628280-26-058333), Form 4 Haskell; 4 filed 2026-08-21 (0002001557-26-000156), Form 4 Brown.
| Tool | Figure | Cites | Source has it | As-of | Links went to |
|---|---|---|---|---|---|
| Signal8 Octo | yes | yes | yes | yes | SEC filing |
| Claude | yes | yes | yes | yes | SEC filing and other sites |
| ChatGPT | no | yes | no | yes | no link captured |
| AskEdgar Studio | no | yes | no | yes | no link captured |
| Perplexity second blind pass | yes | yes | no | yes | other sites only |
| Gemini | No answer recorded (free usage limit) | ||||
What this round does not show
It shows how six tools answered 40 harder filing questions on one day, on the plans stated. The answers cover small and micro caps, where the figure usually sits in an 8-K, a 10-Q footnote or a Form 4. AI products change often, and two tools did not finish. The raw answer text is not published because some answers quote market prices we are not licensed to republish; every grade and grader note is in the CSV. The earlier blind round 2 (questions named their filing) also ranked Octo first, on a different tie-break.